【原著・著書・総説】

1.   Ando M, Higuchi Y, Yuan J, Yoshimura A, Kojima F, Yamanishi Y, Aso Y, Izumi K, Imada M, Maki Y, Nakagawa H, Hobara T, Noguchi Y, Takei J, Hiramatsu Y, Nozuma S, Sakiyama Y, Hashiguchi A, Matsuura E, Okamoto Y, Takashima H.
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan.
Ann Clin Transl Neurol. 2024;11(1):96-104.  doi: 10.1002/acn3.51936. 

2.   Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R, Ishihara S, Tsuboi Y, Katsuno M, Nakagawa M, Matsushita T, Aso Y, Matsuura E, Tokashiki T, Mukaino A, Adachi H, Nakanishi K, Yamaguchi Y, Yamaguchi S, Yamano Y.
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
J Neurol. 2024;Mar 2.  doi: 10.1007/s00415-024-12239-x. Online ahead of print. 

3.   Miyaue N, Kaneko K, Takahashi T, Nagai M.
A case of MOG antibody-associated disease with selective positivity in cerebrospinal fluid using IgG-Fc cell-based assay.
Acta Neurol Belg. 2024;124(2):683-685.  doi: 10.1007/s13760-023-02379-8.

4.   Miyaue N.
16S rRNA Gene Amplicon Analysis of Human Gut Microbiota.
Methods Mol Biol. 2024:2766:343-349.  doi: 10.1007/978-1-0716-3682-4_35.

5.   Miyaue N, Ito Y, Yamanishi Y, Tada S, Ando R, Yabe H, Nagai M.
Optimization of oral entacapone administration in patients undergoing levodopa–carbidopa intestinal gel treatment.
J Neurol Sci. 2024;457:122901.  doi: 10.1016/j.jns.2024.122901.

6.   Tanaka K, Choudhury ME, Kikuchi S, Takeda I, Umakoshi K, Miyaue N, Mikami K, Takenaga A, Yagi H, Shinabe R, Matsumoto H, Yano H, Nagai M, Takeba J, Junya Tanaka J.
A dopamine D1-like receptor-specific agonist improves the survival of septic mice.
iScience. 2024;27(4):109587.  doi: 10.1016/j.isci.2024.109587.

7.   Miyaue N, Ochi C, Ito H. Y, Ando R, Sone J, Nagai M.
Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease.
Intern Med. 2024;63(8):1163-1166.  doi: 10.2169/internalmedicine.2384-23.

8.   永井将弘
パーキンソン病の内科的治療
今日の治療指針2024年版, 975-978, 医学書院

9.   細川裕子,岡田陽子,楠勝介,矢部勇人
長期間の高気圧酸素治療により高次脳機能障害が著明に改善した間歇型一酸化炭素中毒の1例
神経治療.2024; Vol.41(1):69-72. https://doi.org/10.15082/jsnt.41.1_69

【学会・研究会】

1.   第101回日本生理学会大会,福岡(北九州),3.28-30,2024.
・Ayane Takenaga, Mohammed E Choudhury, Naoki Abe, Noriyuki Miyaue, Masahiro Nagai, Tasuku Nishihara, Junya Tanaka.
Ameliorative effects of a dopamine D1-like receptor agonist SKF-81297 on traumatic brain injury model rats by preventing neuroinflammatory reactions.

2.   第13回日本パーキンソン病・運動障害疾患学会教育研修会,青森(弘前),4.14,2024.
・永井将弘
早期パーキンソン病治療のコツ